PPI to Promote the Psychological Well-being of Children Living in Poverty

April 12, 2022 updated by: Dr Eva Ho, The Hong Kong Polytechnic University

The Use of a Positive Psychology Intervention (PPI) to Promote the Psychological Well-being of Children Living in Poverty: a Feasibility Randomized Controlled Trial

Positive psychology interventions use positive psychology techniques to identify meaning and value in life events to raise positive feelings and emotions. Application of PPIs has steadily increased in clinical and non-clinical samples. However, that meta-analysis did not include any study in a Chinese population, and it remains unclear whether PPIs are applicable in the Hong Kong Chinese context.

Study Overview

Status

Recruiting

Intervention / Treatment

Detailed Description

A randomized controlled trial will be conducted. A convenience sample of 120 patients age 13 to 17 years with no cognitive and/or behavioral problem(s) will be recruited in secondary school around Kwai Chung Estate Participants will be randomized into experimental and control group. The experimental group, who will receive a 1.5-hour workshop covering positive psychology techniques delivered by a qualified research assistant, in groups of less than 5 people, and a booster intervention at 1 week. The control group will received no intervention. Data collection will be conducted at baseline, 1 week, 1month, 3months and 6 months for both groups.

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Hong Kong,China
      • Hong Kong, Hong Kong,China, Hong Kong, 000
        • Recruiting
        • Ka Yan Ho

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 17 years (Child)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age from 13-17
  • Can read Chinese and speak Cantonese

Exclusion Criteria:

  • with identified cognitive and/or behavioral problem(s)
  • with identified mental problem(s)
  • participating in any mental health service/programme and/or receiving any psychiatric medication.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
The control group will receive no intervention.
Active Comparator: Positive psychology
The experimental group(n=60), who will receive a 1.5-hour workshop covering positive psychology techniques delivered by a qualified research assistant, in groups of less than 5 people.
This intervention aim to examine the effectiveness of PPI in reducing depressive symptoms, enhancing self-esteem, and promoting quality of life among Chinese children who are living in poverty. Participants in the experimental group will receive a 1.5 hour workshop on 4 positive psychology techniques, including (1) gratitude visit/letters, (2) 3 good things, (3) you at your best, and (4) using signature strengths. A booster intervention will be given at 1-week follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Screening rate
Time Frame: At baseline
The number of children screened by the RA divided by the number of children available for screening during the recruitment period.
At baseline
Eligibility rate
Time Frame: At baseline
The number of eligible children divided by the number of screened children
At baseline
Consent rate
Time Frame: At baseline
The number of eligible children who consent to participate divided by the number of eligible children
At baseline
Randomization rate
Time Frame: At baseline
The number of children randomized to the experimental and control groups divided by the number of consenting children
At baseline
Intervention attendance rate
Time Frame: Immediately after the training workshop
The number of participants in the experimental group who complete the intervention divided by the number of participants randomized into the group
Immediately after the training workshop
Intervention attendance rate at 1-week follow-up
Time Frame: At 1-week follow-up
The number of participants in the experimental group who complete the intervention divided by the number of participants randomized into the group
At 1-week follow-up
Adherence to the intervention protocol at 1-week follow-up
Time Frame: At 1-week follow-up
The number of participants in the experimental group who practice the skills gained divided by the number of participants randomized into the group
At 1-week follow-up
Retention rate at 6-month follow-up
Time Frame: At 6-month follow-up
The number of participants who remain in this study divided by the number of randomized participants, calculated by group at each follow-up
At 6-month follow-up
Completion rate at 6-month follow-up
Time Frame: At 6-month follow-up
The number of participants who return the questionnaires divided by the number of questionnaires distributed
At 6-month follow-up
Missing data at baseline
Time Frame: At baseline
The percentage of missing in the dataset
At baseline
Missing data at 1-week follow-up
Time Frame: At 1-week follow-up
The percentage of missing in the dataset
At 1-week follow-up
Missing data at 1-month follow-up
Time Frame: At 1-month follow-up
The percentage of missing in the dataset
At 1-month follow-up
Missing data at 3-month follow-up
Time Frame: At 3-month follow-up
The percentage of missing in the dataset
At 3-month follow-up
Missing data at 6-month follow-up
Time Frame: At 6-month follow-up
The percentage of missing in the dataset
At 6-month follow-up
Adverse events at baseline
Time Frame: At baseline
unfavorable and unintended events
At baseline
Adverse events at 1-week follow-up
Time Frame: At 1-week follow-up
unfavorable and unintended events
At 1-week follow-up
Adverse events at 1-month follow-up
Time Frame: At 1-month follow-up
unfavorable and unintended events
At 1-month follow-up
Adverse events at 3-month follow-up
Time Frame: At 3-month follow-up
unfavorable and unintended events
At 3-month follow-up
Adverse events at 6-month follow-up
Time Frame: At 6-month follow-up
unfavorable and unintended events
At 6-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chinese version of the Rosenberg Self-esteem Scale at 6-month follow-up
Time Frame: At 6-month follow-up
Assess participants' self-esteem
At 6-month follow-up
Chinese version of the Pediatric Quality of Life Inventory at 6-month follow-up
Time Frame: At 6-month follow-up
Assess participants' quality of life
At 6-month follow-up
Chinese version of The Center for Epidemiologic Studies Depression Scale for Children at 6-month follow-up
Time Frame: At 6-month follow-up
Assess participants' depressive symptoms
At 6-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Eva Ho, PhD, The Hong Kong Polytechnic University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2021

Primary Completion (Anticipated)

August 30, 2023

Study Completion (Anticipated)

August 30, 2023

Study Registration Dates

First Submitted

April 20, 2021

First Submitted That Met QC Criteria

May 3, 2021

First Posted (Actual)

May 6, 2021

Study Record Updates

Last Update Posted (Actual)

April 19, 2022

Last Update Submitted That Met QC Criteria

April 12, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • PPI_poverty

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescent Development

Clinical Trials on Positive Psychology

3
Subscribe